Q1 2024 Holdings
Filed 2024-05-13 | 368 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Trade Desk Inc(TTD) | Common Stock | 88339J105 | $325.5K | 3,723 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | Common Stock | 74366E102 | $327.0K | 11,304 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $330.0K | 4,871 | 0.0% |
| Boston Scientific Corp(BSX) | Common Stock | 101137107 | $330.3K | 4,823 | 0.0% |
| Baker Hughes Co(BKR) | Common Stock | 05722G100 | $331.2K | 9,886 | 0.0% |
| ImmunityBio Inc(IBRX) | Common Stock | 45256X103 | $332.5K | 61,922 | 0.0% |
| Verisk Analytics Inc(VRSK) | Common Stock | 92345Y106 | $333.1K | 1,413 | 0.0% |
| Inhibrx Inc(INBXUSD) | Common Stock | 45720L107 | $333.7K | 9,544 | 0.0% |
| Biomea Fusion Inc(BMEA) | Common Stock | 09077A106 | $337.9K | 22,605 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | Common Stock | 92790C104 | $338.3K | 19,323 | 0.0% |
| CVS Health Corp(CVS) | Common Stock | 126650100 | $339.4K | 4,255 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD) | Common Stock | 004225108 | $341.8K | 18,488 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | Common Stock | 110122108 | $344.4K | 6,350 | 0.0% |
| Electronic Arts Inc(EA) | Common Stock | 285512109 | $345.5K | 2,604 | 0.0% |
| Sage Therapeutics Inc(SG7) | Common Stock | 78667J108 | $347.5K | 18,544 | 0.0% |
| Cigna Group(CI) | Common Stock | 125523100 | $348.3K | 959 | 0.0% |
| Akero Therapeutics Inc(AKRO) | Common Stock | 00973Y108 | $351.1K | 13,899 | 0.0% |
| Prothena Corp PLC(PRTA) | Common Stock | G72800108 | $355.2K | 14,340 | 0.0% |
| Vera Therapeutics Inc(VERA) | Common Stock | 92337R101 | $356.2K | 8,260 | 0.0% |
| Medtronic PLC(MDT) | Common Stock | G5960L103 | $359.4K | 4,124 | 0.0% |
| Stryker Corp(SYK) | Common Stock | 863667101 | $362.9K | 1,014 | 0.0% |
| Ardelyx Inc(ARDX) | Common Stock | 039697107 | $364.0K | 49,868 | 0.0% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common Stock | 14888U101 | $366.7K | 23,003 | 0.0% |
| Morphic Holding Inc | Common Stock | 61775R105 | $367.3K | 10,434 | 0.0% |
| Exelon Corp(EXC) | Common Stock | 30161N101 | $369.4K | 9,831 | 0.0% |
| Elevance Health Inc(ELV) | Common Stock | 036752103 | $369.7K | 713 | 0.0% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common Stock | 04280A100 | $370.5K | 12,956 | 0.0% |
| Keros Therapeutics Inc(KROS) | Common Stock | 492327101 | $373.9K | 5,648 | 0.0% |
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $374.3K | 5,491 | 0.0% |
| PulteGroup Inc(PHM) | Common Stock | 745867101 | $374.4K | 3,104 | 0.0% |
| TE Connectivity Ltd(TEL) | Common Stock | H84989104 | $374.9K | 2,581 | 0.0% |
| Geron Corp(GERN) | Common Stock | 374163103 | $376.0K | 113,941 | 0.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | Common Stock | 09058V103 | $376.8K | 74,180 | 0.0% |
| Weibo Corp(WB) | ADR | 948596101 | $377.4K | 41,516 | 0.0% |
| Celldex Therapeutics Inc(CLDX) | Common Stock | 15117B202 | $379.7K | 9,046 | 0.0% |
| Novavax Inc(NVAX) | Common Stock | 670002401 | $380.1K | 79,514 | 0.0% |
| Beam Therapeutics Inc(BEAM) | Common Stock | 07373V105 | $381.5K | 11,547 | 0.0% |
| Arcutis Biotherapeutics Inc(ARQT) | Common Stock | 03969K108 | $385.2K | 38,866 | 0.0% |
| Nuvalent Inc(NUVL) | Common Stock | 670703107 | $385.7K | 5,136 | 0.0% |
| Recursion Pharmaceuticals Inc(RXRX) | Common Stock | 75629V104 | $386.1K | 38,727 | 0.0% |
| CoStar Group Inc(CSGP) | Common Stock | 22160N109 | $388.2K | 4,019 | 0.0% |
| Charter Communications Inc(CHTR) | Common Stock | 16119P108 | $392.6K | 1,351 | 0.0% |
| TG Therapeutics Inc(TGTX) | Common Stock | 88322Q108 | $392.8K | 25,826 | 0.0% |
| Illumina Inc(ILMN) | Common Stock | 452327109 | $394.8K | 2,875 | 0.0% |
| Twist Bioscience Corp(TWST) | Common Stock | 90184D100 | $395.8K | 11,535 | 0.0% |
| Diamondback Energy Inc(FANG) | Common Stock | 25278X109 | $397.5K | 2,006 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | Common Stock | 45826J105 | $397.8K | 14,460 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | Common Stock | 90400D108 | $400.5K | 8,577 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | Common Stock | 501575104 | $400.6K | 9,965 | 0.0% |
| Alkermes PLC(ALKS) | Common Stock | G01767105 | $401.1K | 14,816 | 0.0% |